type here...

CATEGORIES

Medication

LATEST

1234Page 1 of 4

TRENDING

EDITORS CHOICE

How Dare You Criticize Psychiatrists Who Praise Studies of Psychedelics As Antidepressants?

James Coyne -
All claims about treatments affecting human health and well-being should be subject to robust review. That review requires someone to facilitate criticism, locate qualified critics, and bring them into the discussion.

2024 Health Trends: Progress, Challenges, and Opportunities

Gil Bashe, Medika Life Editor -
Here are 10 health-sector developments—not ranked—to watch in the coming year, determined by media coverage, reader interest, and personal interest.

SUICIDE: IS AI RESPONSIBLE?

Christi Taylor-Jones -
The Raines discovered their son Adam in the closet where he hung himself with the support of a character on ChatGPT with whom he’d...

FDA Approval of New Drug for Alzheimer’s Offers Hope

Dr Jeff Livingston -
The FDA approves Aduhelm for the treatment of early Alzheimer's disease. Aduhelm targets brain plaque formation to slow the rate of cognitive decline.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories